These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6153074)

  • 1. Liver-specific antigen (LSP)--a controversy.
    Behrens UJ; Paronetto F
    Gastroenterology; 1980 Feb; 78(2):424-5. PubMed ID: 6153074
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).
    McFarlane IG; McFarlane BM; Major GN; Tolley P; Williams R
    Clin Exp Immunol; 1984 Feb; 55(2):347-54. PubMed ID: 6199139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody to liver-specific lipoprotein in the mouse: regulation by naturally occurring autoantigen specific suppressor cells.
    Bartholomaeus WN; Reed WD; Joske RA
    Clin Exp Immunol; 1984 Nov; 58(2):307-16. PubMed ID: 6209041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease.
    Feighery C; McDonald GS; Greally JF; Weir DG
    Clin Exp Immunol; 1981 Jul; 45(1):143-51. PubMed ID: 7307345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-antigen in liver injury.
    Espinosa E; Bull DM; Arakawa Y
    Gastroenterology; 1977 May; 72(5 Pt 1):985-6. PubMed ID: 66168
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver membrane autoantibodies: methods for their detection and clinical significance.
    Nagai S; Manns M; Meyer zum Büschenfelde KH
    Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Purification, characterization and clinical aspects of a liver specific antigen].
    Mafune N
    Hokkaido Igaku Zasshi; 1982 Jul; 57(4):491-501. PubMed ID: 7173815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigens of the human liver.
    McFarlane IG; Wojcicka BM; Williams R
    Clin Exp Immunol; 1980 Apr; 40(1):1-7. PubMed ID: 6156044
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological reactions to liver-specific membrane lipoprotein (LSP) in experimental autoimmune liver disease in rabbits.
    Uibo RM; Helin HJ; Krohn KJ
    Clin Exp Immunol; 1982 May; 48(2):505-12. PubMed ID: 7105494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody responses to liver-specific lipoprotein in mice.
    Bartholomaeus WN; Reed WD; Joske RA; Shilkin KB
    Immunology; 1981 Jun; 43(2):219-26. PubMed ID: 7019049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meyer's antigen (liver specific antigen)].
    Kawakami H; Miyoshi A
    Nihon Rinsho; 1978 May; Suppl():2206-7. PubMed ID: 691697
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunopathological mechanisms responsible for hepatic lesions caused by B virus].
    Vuitton D; Trepo C
    Pathol Biol (Paris); 1984 Mar; 32(3):190-8. PubMed ID: 6201804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of autoimmune hepatitis with hot labelled liver specific antigen.
    Fehér J; Filipp G; Kocsár L; Mohari K; Toncsev H; Fehér E; Biro G
    Clin Exp Immunol; 1984 Feb; 55(2):360-8. PubMed ID: 6697567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to liver-specific lipoprotein following hepatitis induced by mouse cytomegalovirus.
    Bartholomaeus WN; Shellam GR; Allan JE; Reed WD; Joske RA
    Clin Exp Immunol; 1983 Apr; 52(1):89-97. PubMed ID: 6305543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in the expression of a beta 2-microglobulin epitope on hepatocytes in chronic type C hepatitis on treatment with interferon.
    García-Buey L; López-Botet M; García-Sánchez A; Balboa MA; Aramburu J; García-Monzón C; Acevedo A; Moreno-Otero R
    Hepatology; 1993 Mar; 17(3):372-82. PubMed ID: 7680330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intrahepatic antigen-specific retention of naïve CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice.
    Bertolino P; Schrage A; Bowen DG; Klugewitz K; Ghani S; Eulenburg K; Holz L; Hogg N; McCaughan GW; Hamann A
    Hepatology; 2005 Nov; 42(5):1063-71. PubMed ID: 16250049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen.
    Sagnelli E; Felaco FM; Triolo G; Vernace SJ; Filippini P; Piccinino F; Behrens U; Paronetto F
    J Clin Lab Immunol; 1983 Sep; 12(1):11-5. PubMed ID: 6195340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of cellular immunity in experimental autoimmune hepatitis in mice.
    Mori Y; Mori T; Yoshida H; Ueda S; Iesato K; Wakashin Y; Wakashin M; Okuda K
    Clin Exp Immunol; 1984 Jul; 57(1):85-92. PubMed ID: 6430615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
    Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
    Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.